放疗诱导与动脉粥样硬化性颈动脉狭窄支架置入后再狭窄的25年比较
单中心25年回顾性研究纳入126例患者共140例次颈动脉支架置入术,倾向性评分匹配后放疗诱导组与动脉粥样硬化组各40例次。放疗诱导组≥50%支架内再狭窄显著更高(40% vs 12.5%,P=0.005),既往颈部放疗是唯一独立危险因素(OR 7.05,95%CI 1.26-39.45,P=0.026),但再干预率和晚期同侧神经事件两组相当。
要点
- 放疗诱导性颈动脉狭窄CAS后≥50%支架内再狭窄率显著高于动脉粥样硬化组。
- 既往颈部放疗是≥50%支架内再狭窄的唯一独立危险因素(OR 7.05)。
- 两组再干预率及晚期同侧神经事件相当,近期他汀使用增加伴再狭窄下降。
核心结论
- 放疗诱导性颈动脉狭窄患者CAS后长期中度(≥50%)支架内再狭窄率高于动脉粥样硬化性狭窄患者。
- 两组再干预率和晚期同侧神经事件率相当,近期再狭窄发生率下降与他汀使用增加及血脂优化管理同步。
研究设计与样本
- 单中心25年回顾性队列研究,纳入126例患者共140例次颈动脉支架置入术。
- 有颈部放疗史者归为放疗诱导组,其余归为动脉粥样硬化组,采用倾向性评分匹配平衡基线特征。
- 匹配后每组各40例次,中位随访72个月,用经验证的支架动脉双功超声速度标准评估再狭窄。
主要发现
- 放疗诱导组≥50%支架内再狭窄发生率为40%,动脉粥样硬化组为12.5%(P=0.005)。
- 放疗诱导组≥50%支架内再狭窄或支架段外新发狭窄复合终点为55%,动脉粥样硬化组为17.5%(P<0.001)。
- 放疗诱导组≥50%再狭窄的2年无再狭窄生存估计为75.5%,动脉粥样硬化组为94.8%(P=0.005)。
- 多因素分析显示既往颈部放疗是≥50%支架内再狭窄的唯一独立危险因素(OR 7.05,95%CI 1.26-39.45,P=0.026)。
- ≥70%支架内再狭窄未发现显著危险因素;按年代分析显示放疗诱导组近期≥50%和≥70%再狭窄发生率显著下降。
关键数值与推荐
- 再狭窄评估采用针对支架动脉验证的双功超声速度标准。
- 比较中度(≥50%)和重度(≥70%)支架内再狭窄率。
- 放疗诱导组≥50%再狭窄率40% vs 动脉粥样硬化组12.5%(P=0.005)。
- 放疗诱导组2年≥50%无再狭窄生存75.5% vs 动脉粥样硬化组94.8%(P=0.005)。
- 既往颈部放疗为≥50%支架内再狭窄独立危险因素(OR 7.05,95%CI 1.26-39.45,P=0.026)。
临床怎么用
- 对既往颈部放疗的颈动脉狭窄患者行CAS后应加强超声随访监测支架内再狭窄。
- 放疗诱导组再狭窄风险高但再干预率和神经事件与动脉粥样硬化组相当,决策需个体化。
- 近期他汀使用增加和血脂优化管理可能与再狭窄率下降相关,支持强化降脂治疗。
局限性
- 单中心回顾性研究,样本量有限(匹配后每组40例次)。
- 按年代分析中基线特征(如高脂血症患病率和他汀使用)发生变化,可能影响再狭窄率比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To compare the long-term in-stent restenosis (ISR) rate following carotid artery stenting (CAS) in patients with carotid stenosis secondary to atherosclerosis (AS) and radiation-induced stenosis (RIS). METHODS: A retrospective review was conducted on 140 CAS procedures in 126 patients at our institution over a 25-year period. Patients with prior neck irradiation were classified as RIS, while the remaining were categorized as AS. Propensity score matching was employed to balance baseline characteristics between the groups. Restenosis was evaluated using specific duplex ultrasound velocity criteria validated for stented arteries. Rates of moderate (≥50%) and severe (≥70%) ISR were compared, and long-term restenosis-free survival was estimated using Kaplan-Meier analysis. Multivariate logistic regression was used to determine independent risk factors for ISR. RESULTS: After matching, 40 CAS procedures were included in each group (RIS and AS). Median follow-up duration was 72 months. The RIS group exhibited a significantly higher prevalence of ≥50% ISR (40% vs. 12.5%; P = 0.005) and a composite endpoint of ≥50% ISR or new stenosis outside the stented segment (55% vs. 17.5%; P < 0.001). The estimated 2-year ISR-free survival at ≥50% was 75.5% in RIS compared to 94.8% in AS (P = 0.005). Multivariate analysis identified prior neck irradiation as the sole independent risk factor for ≥50% ISR (odds ratio 7.05, 95% confidence interval 1.26-39.45, P = 0.026). No significant risk factors were found for ≥70% ISR. Era-based analysis demonstrated a significant decrease in the incidence of ≥50% and ≥70% ISR in the RIS group during the more recent period, accompanied by shifts in baseline characteristics such as prevalence of hyperlipidemia and statin use. Reintervention rate and late ipsilateral neurological events were comparable between the groups. CONCLUSION: Radiation-induced carotid stenosis is associated with higher rates of long-term moderate (≥50%) ISR following CAS compared with atherosclerotic disease. However, reintervention and late ipsilateral neurological event rates remain comparable between groups. Recent temporal declines in restenosis coincide with increased statin use and optimized hyperlipidemia management.
引用
- Tam JS, Fung NY, Ling PZ, et al. Restenosis after Carotid Artery Stenting in Radiation-Induced versus Atherosclerotic Carotid Stenosis: 25-Year Experience from a Tertiary Hospital. Ann Vasc Surg. 2026. PMID: 42838483. doi:10.1016/j.avsg.2026.09.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。